Top Markets
#1 DogBull DogBull +107.67%
#2 MarsCoin MarsCoin +53.34%
#3 Siacoin Siacoin +51.79%
#4 The Bitcoin Bull The Bitcoin Bull +33.48%
#5 ADO Protocol ADO Protocol +28.63%
#6 Ontology Gas Ontology Gas +17.65%
#7 UnifAI Network UnifAI Network +12.27%
#8 Cash Cat Cash Cat +11.74%
#9 Akedo Akedo +10.76%
#10 Apertum Apertum +10.14%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Classifica tra le azioni #14772
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Prezzo delle azioni
$16.85
Ultima sincronizzazione: 2023-07-07
Capitalizzazione di mercato
$393.50M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
CH
Scambia VectivBio Holding AG (VECT)

Categoria

Healthcare
Rapporto P/B per VectivBio Holding AG (VECT)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di VectivBio Holding AG, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per VectivBio Holding AG da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.828 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.5116 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9942 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.2199 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH